DNM1L and lung carcinoma: Our study demonstrates that Drp1 is involved in the regulation of proliferation, invasion, and migration of lung cancer cells in vitro, and inhibiting the signal pathway of Drp1 will contribute to the development of an anti-tumor therapy for lung cancer.